Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
Hai-Ling Margaret Cheng is a principal investigator at our Translational Biology and Engineering Program, whose lab focuses on developing new magnetic resonance technologies for improved cardiac diagnostics. These insights and capabilities will enable the investigation of novel therapies to regenerate new, healthy heart tissue.
For more details on the true potential of advanced imaging as it relates to heart failure, see Prof. Cheng’s commentary from February 2017.